Canadian Pharmacy Blog

Novartis is suspending the marketing and sales of tegaserod maleate (Zelnorm drug) in the U.S. This medication is indicated for patients with irritable bowel syndrome (IBS) plus constipation and for those with chronic constipation, including symptoms such as abdominal pain and bloating. When generic tegaserod was approved in 2002, a statistically nonsignificant imbalance in cases [...]